Most Recent

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

6 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Rebuffing RAS Reform

Opinion: Rebuffing RAS Reform

By | September 19, 2013

On the impending changes to the Russian Academy of Sciences

0 Comments

image: Opinion: Restoring Tomato Flavor

Opinion: Restoring Tomato Flavor

By | August 28, 2013

Commercial tomatoes rarely have that fresh vine-ripened flavor that everyone loves, but the ideal recipe for tomato taste is now known. Will growers embrace the new cultivars?

4 Comments

image: Opinion: The Payoff of Big Science

Opinion: The Payoff of Big Science

By | June 3, 2013

Was the Human Genome Project the key to a gold mine?

3 Comments

image: Opinion: Life as a Target

Opinion: Life as a Target

By | March 27, 2013

Attacks on my work aimed at undermining climate change science have turned me into a public figure. I have come to embrace that role.

33 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS